Systemic and myocardial inflammation in traditional and off-pump cardiac surgery.

In this study, we attempted to determine the role of off-pump coronary artery bypass grafting (CABG) in the myocardial and systemic inflammatory responses. Twenty patients who underwent elective CABG were enrolled in this study. Ten patients underwent on-pump CABG, and 10 patients underwent off-pump CABG. There were no differences between patients in preoperative clinical variables. We took systemic venous blood samples for the measurement of tumor necrosis factor-alpha, the MB isoenzyme of creatine kinase (CK-MB), and cardiac troponin I, and we took myocardial biopsies from the interventricular septum for chemiluminescence assay of reactive oxygen species (hydroxyl, hydrogen peroxide, hypochlorite, and superoxide). There was no significant difference in the myocardial tissue release of hydrogen peroxide, hydroxyl, hypochlorite, and superoxide between the 2 groups (P > 0.05). The systemic tumor necrosis factor-alpha levels in the off-pump group were significantly lower than in the on-pump group (P <0.01). The cardiac troponin I and creatine kinase-MB levels at 6, 12, and 24 postoperative hours were not statistically different between the 2 groups (P >0.05). We conclude that off-pump CABG appears to reduce systemic inflammation, without reducing myocardial oxidative stress and inflammation.

[1]  Song Wan,et al.  Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study. , 2004, The Journal of thoracic and cardiovascular surgery.

[2]  R. Griffiths,et al.  Ischemia and reperfusion of skeletal muscle lead to the appearance of a stable lipid free radical in the circulation. , 2003, American journal of physiology. Heart and circulatory physiology.

[3]  N. Smedira,et al.  Does off-pump coronary surgery reduce morbidity and mortality? ☆ ☆☆ , 2002 .

[4]  L. Bonchek Off-pump coronary bypass: Is it for everyone? , 2002, The Journal of thoracic and cardiovascular surgery.

[5]  H. Kontos,et al.  Oxygen radicals in cerebral ischemia: the 2001 Willis lecture. , 2001, Stroke.

[6]  I. Hassinen,et al.  Myocardial preservation during coronary surgery with and without cardiopulmonary bypass. , 2001, The Annals of thoracic surgery.

[7]  M. Galiñanes,et al.  Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. , 2000, The Annals of thoracic surgery.

[8]  A. Bochenek,et al.  Cardiac troponin T release during coronary surgery using intermittent cross-clamp with fibrillation, on-pump and off-pump beating heart. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  A. Liebold,et al.  The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  S. Gundry,et al.  Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass. , 1998, The Journal of thoracic and cardiovascular surgery.

[11]  J. Babin-Ebell,et al.  The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I. , 1997 .

[12]  P. Parsons,et al.  Oxidant-antioxidant balance in endotoxin-induced oxidative injury and tolerance to oxidative injury , 1994 .

[13]  D. Shale,et al.  Systemic inflammatory responses to cardiopulmonary bypass: a pilot study of the effects of pentoxifylline. , 1993, Respiratory medicine.

[14]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[15]  T. Evans,et al.  Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  D. Rampton,et al.  Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. , 1992, Gastroenterology.

[17]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.